🇺🇸 FDA

Drug profile · INN

betamethasone dipropionate

LOTRISONE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

betamethasone dipropionate (LOTRISONE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN betamethasone dipropionate
Brand LOTRISONE
Route TOPICAL
Formulation GEL, AUGMENTED

Frequently asked questions

What is betamethasone dipropionate?

betamethasone dipropionate (LOTRISONE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for betamethasone dipropionate?

LOTRISONE is a marketed brand name for betamethasone dipropionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of betamethasone dipropionate?

betamethasone dipropionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.